Literature DB >> 19082597

Prevalence of spondyloarthritis in Turkish patients with inflammatory bowel disease.

Asli Beslek1, Fatos Onen, Merih Birlik, Mesut Akarsu, Servet Akar, Ismail Sari, Oguz Gurler, Hale Akpinar, Metin Manisali, Nurullah Akkoc.   

Abstract

Rheumatic manifestations are the most common extraintestinal findings of inflammatory bowel disease (IBD), although there are wide variations among different studies. The only previous Turkish study reported a rather high prevalence of spondyloarthritis (SpA) in patients with IBD. We aimed to determine the frequency of SpA and ankylosing spondylitis (AS) in patients with IBD attending a gastroenterology clinic from a referral centre. The study was conducted in 122 patients with established diagnosis of IBD [28 with Crohn's disease (CD) and 94 with ulcerative colitis (UC)]. A detailed medical history was obtained and a complete physical examination was performed in all the patients. Standard pelvic X-rays for examination of the sacroiliac joints were performed only when clinically indicated. The X-rays were read blindly by an experienced rheumatologist and reported according to the established grading system. The modified New York criteria were used to classify AS, and the European Spondyloarthropathy Study Group criteria for SpA. The prevalence of AS and SpA in patients with IBD was 8.2 and 28.7%, respectively. SpA was found to be significantly more common in the patients with CD compared to patients with UC, but the frequency of AS was not different between these two groups. There was no correlation between localisation or extent of the intestinal inflammation and presence of AS and SpA. A higher frequency of women was observed in patients diagnosed as SpA. Almost half of the patients with SpA (45.7%) had not been diagnosed before the study, although they had a history of IBP and/or peripheral arthritis. This study suggests that the prevalences of SpA and AS in Turkish patients with IBD are similar to those in many other populations. There may be a significant female predominance of SpA among patients with IBD.

Entities:  

Mesh:

Year:  2008        PMID: 19082597     DOI: 10.1007/s00296-008-0811-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  12 in total

1.  Clinical history as a screening test for ankylosing spondylitis.

Authors:  A Calin; J Porta; J F Fries; D J Schurman
Journal:  JAMA       Date:  1977-06-13       Impact factor: 56.272

2.  Prevalence of spondyloarthropathies in France: 2001.

Authors:  A Saraux; F Guillemin; P Guggenbuhl; C H Roux; P Fardellone; E Le Bihan; A Cantagrel; I Chary-Valckenaere; L Euller-Ziegler; R-M Flipo; R Juvin; J-M Behier; B Fautrel; C Masson; J Coste
Journal:  Ann Rheum Dis       Date:  2005-04-07       Impact factor: 19.103

3.  Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists.

Authors:  B Moum; M H Vatn; A Ekbom; E Aadland; O Fausa; I Lygren; J Sauar; T Schulz; N Stray
Journal:  Scand J Gastroenterol       Date:  1996-04       Impact factor: 2.423

4.  The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease.

Authors:  Nuran Turkcapar; Murat Toruner; Irfan Soykan; Olcay Tiryaki Aydintug; Hulya Cetinkaya; Nursen Duzgun; Ali Ozden; Murat Duman
Journal:  Rheumatol Int       Date:  2005-09-01       Impact factor: 2.631

5.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

Review 6.  Muscoloskeletal manifestations in inflammatory bowel disease.

Authors:  G Fornaciari; C Salvarani; M Beltrami; P Macchioni; R W Stockbrügger; M G Russel
Journal:  Can J Gastroenterol       Date:  2001-06       Impact factor: 3.522

7.  Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association.

Authors:  K de Vlam; H Mielants; C Cuvelier; F De Keyser; E M Veys; M De Vos
Journal:  J Rheumatol       Date:  2000-12       Impact factor: 4.666

8.  Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients.

Authors:  C Salvarani; I G Vlachonikolis; D M van der Heijde; G Fornaciari; P Macchioni; M Beltrami; I Olivieri; F Di Gennaro; P Politi; R W Stockbrügger; M G Russel
Journal:  Scand J Gastroenterol       Date:  2001-12       Impact factor: 2.423

9.  The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy.

Authors:  M Dougados; S van der Linden; R Juhlin; B Huitfeldt; B Amor; A Calin; A Cats; B Dijkmans; I Olivieri; G Pasero
Journal:  Arthritis Rheum       Date:  1991-10

10.  Prevalence of ankylosing spondylitis and related spondyloarthritides in an urban area of Izmir, Turkey.

Authors:  Fatos Onen; Servet Akar; Merih Birlik; Ismail Sari; Muhammad Asim Khan; Oguz Gurler; Alp Ergor; Metin Manisali; Nurullah Akkoc
Journal:  J Rheumatol       Date:  2007-12-15       Impact factor: 4.666

View more
  9 in total

1.  Prevalence of self-reported spondyloarthritis features in a cohort of patients with inflammatory bowel disease.

Authors:  Carmen Stolwijk; Marieke Pierik; Robert Landewé; Ad Masclee; Astrid van Tubergen
Journal:  Can J Gastroenterol       Date:  2013-04       Impact factor: 3.522

Review 2.  Epidemiology of spondyloarthritis.

Authors:  Carmen Stolwijk; Annelies Boonen; Astrid van Tubergen; John D Reveille
Journal:  Rheum Dis Clin North Am       Date:  2012-08       Impact factor: 2.670

3.  Direct and indirect costs associated with ankylosing spondylitis and related disease activity scores in Turkey.

Authors:  Nurullah Akkoç; Haner Direskeneli; Hakan Erdem; Ahmet Gül; Yasemin Kabasakal; Sedat Kiraz; Dilara Balkan Tezer; Başak Hacıbedel; Vedat Hamuryudan
Journal:  Rheumatol Int       Date:  2015-03-07       Impact factor: 2.631

4.  A Case of Human Leukocyte Antigen (HLA) B27-Positive Intestinal Behçet's Disease with Crohn's Disease-Like Anal Fistulas.

Authors:  Tsuyoshi Kobashigawa; Yuki Nanke; Masakazu Takazoe; Kuniko Iihara; Hisashi Yamanaka; Shigeru Kotake
Journal:  Clin Med Insights Case Rep       Date:  2014-04-27

5.  Relationship between articular and nonarticular manifestations in inflammatory bowel diseases.

Authors:  Alimohammad Fatemi; Hourossadat Hashemi Jazi; Mohammad Hasan Emami; Amir Kazemizadeh; Hamid Tavakkoli; Abbas Smiley
Journal:  J Res Med Sci       Date:  2016-06-14       Impact factor: 1.852

6.  Health care costs associated with ankylosing spondylitis in Turkey: an analysis from nationwide real-world data.

Authors:  Onur Baser; Abdulkadir Burkan; Erdem Baser; Rasim Koselerli; Emre Ertugay; Akif Altinbas
Journal:  Int J Rheumatol       Date:  2013-02-19

7.  Clinical features of Crohn disease concomitant with ankylosing spondylitis: A preliminary single-center study.

Authors:  Song Liu; Jie Ding; Meng Wang; Wanqing Zhou; Min Feng; Wenxian Guan
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

8.  Rheumatic manifestations of inflammatory bowel diseases: A study from the Middle East.

Authors:  Mohammed Hammoudeh; Eman Elsayed; Saad Al-Kaabi; Manik Sharma; Mohamed Elbadri; Prem Chandra; Niveen Abu Nahia; Samer Hammoudeh
Journal:  J Int Med Res       Date:  2018-07-02       Impact factor: 1.671

Review 9.  Spondyloarthritis in inflammatory bowel disease cohorts: systematic literature review and critical appraisal of study designs.

Authors:  Monica Schwartzman; Joerg Ermann; Kristine A Kuhn; Sergio Schwartzman; Michael H Weisman
Journal:  RMD Open       Date:  2022-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.